Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study

BACKGROUND: Tyrosine kinase inhibitors (TKIs) and checkpoint inhibitors have been established as effective treatment for metastatic renal cell carcinoma (mRCC), but only a minority of patients achieve complete response. Additional strategies are necessary to improve these agents’ efficacy. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Dengina, Natalia, Mitin, Timur, Gamayunov, Sergey, Safina, Sufia, Kreinina, Yuliya, Tsimafeyeu, Ilya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802957/
https://www.ncbi.nlm.nih.gov/pubmed/31673426
http://dx.doi.org/10.1136/esmoopen-2019-000535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802957/
https://www.ncbi.nlm.nih.gov/pubmed/31673426
http://dx.doi.org/10.1136/esmoopen-2019-000535

Ejemplares similares